Related Experiment Video
Updated: May 4, 2026

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
Published on: July 4, 2007
The delicate balance in genetically engineering live vaccines.
1Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Division of Geographic Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Engineered live vaccines use precise strategies for better immunogenicity. Balancing attenuation and immunogenicity is key for effective vaccine development and public health expansion.
Area of Science:
- Vaccinology
- Genetic Engineering
- Immunology
Background:
- Traditional vaccine development is shifting towards precise engineering strategies.
- Live attenuated vaccines are crucial for inducing robust immune responses.
Purpose of the Study:
- To review engineering techniques for creating attenuated vaccines.
- To explore multivalent vaccine platforms for broad immunization.
- To emphasize the balance between attenuation and immunogenicity.
Main Methods:
- Surveying genetic engineering techniques for vaccine attenuation.
- Adapting attenuated strains into multivalent vaccine carriers.
- Applying engineering logic to enteric vaccine development.
Main Results:
- Engineered vaccines can deliver antigens to lymphoid sites for dual immunity.
- Successful engineered vaccines require a balance between attenuation and immunogenicity.
- Genetic engineering accelerates vaccine development for novel applications.
Conclusions:
- Genetic engineering offers powerful tools for modern vaccine design.
- Achieving the right attenuation-immunogenicity balance is critical for vaccine efficacy and safety.
- Engineered vaccines have the potential to significantly expand the role of vaccines in public health.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
Related Concept Videos
Vaccine Production
Microorganisms in Medicine and Therapeutics
What is Genetic Engineering?
Vaccines
Vaccinations